Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACPA-Positive & ACPA-Negative Patients with RA: The Difference Begins in the Lungs

Lara C. Pullen, PhD  |  January 4, 2016

Senior investigator Anca I. Catrina, MD, PhD, is an associate professor at the Karolinska Intitutet. She wrote by e-mail to The Rheumatologist to further explain the relationship between the lung and RA.

“The lung is one among several mucosal sites in our body, where the environment—such as smoking—is challenging the host and its genes, and interferes with the local microbiome,” she says. “Therefore, it is easy to find an explanation for why initiation of RA associate immunity [may] take place in the lungs.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She also noted that other mucosal sites, such as the gingiva and intestinal mucosa, might also contribute to disease pathogenesis, thereby substituting for the lungs.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Reynisdottir G, Olsen H, Joshua V, et al. Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis. Ann Rheum Dis. 2015 Nov 3. pii: annrheumdis-2015-208216. doi: 10.1136/annrheumdis-2015-208216. [Epub ahead of print]

Revised on 1/12/2016 to correct references to “citrullinated proteins.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:ACPAanti-citrullinated protein antibodieslunglung diseaseRheumatoid Arthritis (RA)

Related Articles

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    October 11, 2016

    Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue. Usually, early diagnosis means spotting the clinical signs of disease, but new research tells us more about…

    What Listening to Lungs Might Teach About Rheumatic Disease

    February 17, 2016

    One of your first clinical assignments as a medical student was likely to have been the lung exam. Its key descriptors may still resonate in your mind: inspection, palpation, percussion and auscul­tation. Proudly parading down the hospital corridors, your newly purchased stethoscope snugly tucked inside your lab coat pocket, you carefully place its cold metal…

    Bronchial Tissue Immune Activation Seen in Early Rheumatoid Arthritis

    November 17, 2015

    NEW YORK (Reuters Health)—Patients with untreated early rheumatoid arthritis (RA) show signs of immune activation and local inflammation in their bronchial tissues, researchers from Sweden report. Previous studies have shown that patients with RA have shared citrullinated epitopes in the lungs and joints, as well as anticitrullinated protein antibodies (ACPA) in bronchoalveolar lavage (BAL), suggesting…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences